Cyclerion Announces Definitive Agreement for Zagociguat and CY3018
11 mai 2023 18h00 HE
|
Cyclerion Therapeutics, Inc.
Certain Cyclerion shareholders and new investors have agreed to invest $81M to launch a new company targeting diseases of mitochondrial dysfunction Cyclerion to receive $8M in cash and 10% equity in...